Bio-friendly encapsulation of superoxide dismutase into vaterite CaCO3 crystals. Enzyme activity, release mechanism, and perspectives for ophthalmology

• Published in: Colloids and surfaces, B, Biointerfaces Vol. 181; pp. 437 - 449
• Main Authors: Binevski, Petr V., Balabushevich, Nadezhda G., Uvarova, Viktoria I., Vikulina, Anna S., Volodkin, Dmitry
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01-09-2019
• Subjects: Calcite; Ocular drug delivery; Protein; Recrystallization; Sustained release; Sustained release; Calcite; Ocular drug delivery; Protein; Recrystallization
• ISSN: 0927-7765; 1873-4367
• DOI: 10.1016/j.colsurfb.2019.05.077

[Display omitted]
•Co-synthesis of superoxide dismutase (SOD) at pH 8.5 retains fully SOD bioactivity.•Enormous SOD amount in crystals (10−2 M) due to SOD aggregation during co-synthesis.•SOD release governed by aggregate dissolution and diffusion thorough crystal pores.•Bi-modal SOD release kinetics ends with entire release due to recrystallization.
Mesoporous vaterite CaCO3 crystals are nowadays one of the most popular vectors for loading of fragile biomolecules like proteins due to biocompatibility, high loading capacity, cost effective and simple loading procedures. However, recent studies reported the reduction of bioactivity for protein encapsulation into the crystals in water due to rather high alkaline pH of about 10.3 caused by the crystal hydrolysis. In this study we have investigated how to retain the bioactivity and control the release rate of the enzyme superoxide dismutase (SOD) loaded into the crystals via co-synthesis. SOD is widely used as an antioxidant in ophthalmology and its formulations with high protein content and activity as well as opportunities for a sustained release are highly desirable. Here we demonstrate that SOD co-synthesis can be done at pH 8.5 in a buffer without affecting crystal morphology. The synthesis in the buffer allows reaching the high loading efficiency of 93%, high SOD content (24 versus 15 w/w % for the synthesis in water), and order of magnitude higher activity compared to the synthesis in water. The enormous SOD concentration into crystals of 10−2 M is caused by the entrapment of SOD aggregates into the crystal pores. The SOD released from crystals at physiologically relevant ionic strength fully retains its bioactivity. As found by fitting the release profiles using zero-order and Baker-Lonsdale models, the SOD release mechanism is governed by both the SOD aggregate dissolution and by the diffusion of SOD molecules thorough the crystal pores. The latest process contributes more in case of the co-synthesis in the buffer because at higher pH (co-synthesis in water) the unfolded SOD molecules aggregate stronger. The release is bi-modal with a burst (ca 30%) followed by a sustained release and a complete release due to the recrystallization of vaterite crystals to non-porous calcite crystals. The mechanism of SOD loading into and release from the crystals as well as perspectives for the use of the crystals for SOD delivery in ophthalmology are discussed. We believe that together with a fundamental understanding of the vaterite-based protein encapsulation and protein release, this study will help to establish a power platform for a mild and effective encapsulation of fragile biomolecules like proteins at bio-friendly conditions.